Categoría: News
-
Cellular Dynamics and Mount Sinai Sign Licensing Agreement
The Madison, Wisconsin stem cell startup company, Cellular Dynamics, has announced the licensing of cardiovascular cells from New York’s Mount Sinai Medical School.
-
First Patient Treated in Clinical Trial for Hematopoietic Stem Cells
The adult stem cell company Fate Therapeutics announces treatment of the first patient in a Phase 1b clinical trial for hematopoietic stem cell support.
-
Embryonic Stem Cell Advocates Protest NIH Guidelines
Embryonic stem cell scientists complain that the new NIH guidelines would severely restrict the federal funding of embryonic stem cell research.
-
Children’s Hospital of Boston and Fate Therapeutics Sign IP Deal
The adult stem cell company Fate Therapeutics has announced a licensing agreement with Children’s Hospital of Boston.
-
Pluristem Announces Clinical Trial Site, and Receives Patent For Adult Stem Cell Expansion Method
The U.S. Patent and Trademark Office has awarded a patent to Pluristem Therapeutics for the invention of a novel method of expanding hemopoietic stem cells.
-
Adult Human Stem Cells Treat Liver Failure in Mice
Scientists use human adult stem cells from umbilical cord blood to reverse liver failure in mice.
-
Adult Stem Cells Attenuate Immune Rejection
Scientists demonstrate that adult stem cells from bone grafts extend cardiac transplant survival through immune modulation.
-
Horse Wins Event After Adult Stem Cell Treatment
A top British events horse has bounced back to victory after receiving autologous adult stem cell therapy for a tendon injury.
-
Biomechanical Forces Stimulate Blood Stem Cell Production
Researchers have traced the embryological development of blood stem cells to mechanical forces produced by the early embryological heart.